Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy

Neurology

Volumn 54, Issue 7, 2000, Pages 1459-1464

  Kanda, Takashi ^a   Yamawaki, Masanaga ^a   Iwasaki, Takayuki ^a   Mizusawa, Hidehiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antibody; Autoimmune demyelinative neuropathy; Blood nerve barrier; Endothelial cell; Glycosphingolipid

Indexed keywords

ANTIBODY; GLYCOSPHINGOLIPID;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; ENDONEURIUM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMORAL IMMUNITY; MALE; NERVE BIOPSY; PATHOGENESIS; PRIORITY JOURNAL; SURAL NERVE;

EID: 0034636069     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.7.1459     Document Type: Article

References (41)

1. Kohriyama T, Ariga T, Yu RK. Preparation and characterization of antibodies against a sulfated glucuronic acid-containing glycosphingolipid. J Neurochem 1988;51:869-877.
2. Yu RK, Ariga T, Kohriyama T, et al. Autoimmune mechanisms in peripheral neuropathies. Ann Neurol 1990;27:S30-35.
3. Maeda Y, Bigbee JW, Maeda R, et al. Induction of demyelination by intraneural injection of antibodies against sulfoglucuronyl paragloboside. Exp Neurol 1991;113:221-225.
4. Kanda T, Hayashi H, Tanabe H, et al. A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry 1989;52:857-864.
5. Koski CL. Humoral mechanisms in immune neuropathies. Neurol Clin 1992;10:629-649.
6. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78.
7. Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 1991; 14:927-936.
8. Connolly AM, Pestronk A, Trotter JL, et al. High-titer selctive serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy. Neurology 1993;43:557-562.
9. Kanda T, Iwasaki T, Yamawaki M, Ikeda K. Isolation and culture of bovine endothelial cells of endoneurial origin. J Neurosci Res 1997;49:769-777.
10. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;32:958-964.
11. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27(suppl):21-24.
12. Arvidson B. Cellular uptake of exogenous horseradish peroxidase in mouse peripheral nerve. Acta Neuropathol 1977;37: 35-41.
13. Seitz RJ, Heininger K, Schwendemann G, et al. The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system. Acta Neuropathol 1985;68:15-21.
14. Poduslo JF, Curran GL, Berg CT. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci USA 1994;91:5705-5709.
15. Olsson Y, Reese TS. Permeability of vasa nervorum and perineurium in mouse sciatic nerve studied by fluorescence and electron microscopy. J Neuropathol Exp Neurol 1971;30:105-119.
16. Boddingius J. Ultrastructural changes in blood vessels of peripheral nerves in leprosy neuropathy. I. Tuberculoid and borderline-tuberculoid leprosy patients. Acta Neuropathol 1976;35:159-181.
17. Johnson PC. Fenestrated endothelium in the human peripheral nervous system. J Neuropathol Exp Neurol 1977;36: 607. Abstract.
18. Powell HC, Rosoff J, Myers RR. Microangiopathy in human diabetic neuropathy. Acta Neuropathol 1985;68:295-305.
19. Lach B, Rippstein P, Atack D, et al. Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy. Acta Neuropathol 1993;85:298-307.
20. Meier C, Roberts K, Steck A, et al. Polyneuropathy in Waldenström's macroglobulinemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis. Acta Neuropathol 1984;64:297-307.
21. Kanda T, Usui S, Beppu H, et al. Blood-nerve barrier in IgM paraproteinemic neuropathy: a clinicopathologic assessment. Acta Neuropathol 1998;95:184-192.
22. Sima AAF, Nathaniel V, Prashar A, et al. Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysfunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 1991;40:1090-1099.
23. Midroni G, Bilbao JM. Biopsy diagnosis of peripheral neuropathy. Boston: Butterworth-Heinemann, 1995.
24. Ohara S, Ikuta F. On the occurrence of the fenestrated vessels in wallerian degeneration of the peripheral nerve. Acta Neuropathol 1985;68:259-262.
25. Seitz RJ, Reiners K, Himmelmann F, et al. The blood-nerve barrier in wallerian degeneration: a sequential long-term study. Muscle Nerve 1989;12:627-635.
26. Rotshenker S, Aamar S, Barak V. Interleukin-1 activity in lesioned peripheral nerve. J Neuroimmunol 1992;39:75-80.
27. Bourde O, Kiefer R, Toyka KV, Hartung HP. Quantitation of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction. J Neuroimmunol 1996;69:135-140.
28. Hakomori S-I, Igarashi Y. Functional role of glycosphingolipids in cell recognition and signaling. J Biochem 1995;118: 1091-1103.
29. Brewer GJ, Thomas PD. Role of gangliosides in adhesion and conductance change in large spherical model membranes. Biochem Biophys Acta 1984;776:279-287.
30. Page C, Rose M, Yacoub M, Pigott R. Antigenic heterogeneity of vascular endothelium. Am J Pathol 1992;141:673-683.
31. Kanda T, Yoshino H, Ariga T, et al. Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. J Cell Biol 1994;126:235-246.
32. Kanda T, Iwasaki T, Yamawaki M, et al. Effect of cytokines and anti-glycoconjugate antibodies on the integrity of in vitro blood-nerve barrier. Neurology 1999;52(suppl2):A9.
33. Dyer CA. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands. Molec Neurobiol 1993;7:1-22.
34. Rubin LL, Hall DE, Porter S, et al. A cell culture model of the blood-brain barrier. J Cell Biol 1991;115:1725-1735.
35. Stelzner TJ, Weil JV, O'Brien RF. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J Cell Physiol 1989;139:157-166.
36. Oliver JA. Adenylate cyclase and protein kinase C mediate opposite actions on endothelial junctions. J Cell Physiol 1990; 145:536-542.
37. Vuong PT, Malik AB, Nagpala PG, Lum H. Protein kinase C beta modulates thrombin-induced Ca2+ signaling and endothelial permeability increase. J Cell Physiol 1998;175:379-387.
38. Sharief MK, Ingram DA, Swash M. Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barré syndrome. Ann Neurol 1997;42:68-73.
39. Zhu J, Bai XF, Mix E, Link H. Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence. J Neuroimmunol 1997;78:108-116.
40. Creange A, Belec L, Clair B, et al. Circulating transforming growth factor beta 1 (TGF-beta 1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry 1998;64: 162-165.
41. Watanabe O, Arimura K, Kitajima I, et al. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996;347:702.